Knowledge of hepatitis C and awareness of reinfection risk among people who successfully completed direct acting antiviral therapy.

Patients successfully treated with DAAs had a high HCV knowledge. High knowledge and awareness of reinfection among complex patient groups often facing barriers to HCV care is encouraging and emphasizes the positive outcomes of universal access to treatment.